Skip to main content
TipRanks
Go Ultimate75% OFF

C'BON COSMETICS Co., Ltd. (4926) AI Stock Analysis

0 Followers
JP:4926

C'BON COSMETICS Co., Ltd.

(TSE/TYO:4926)

Select Model
Rating:55Neutral
Price Target:JPY 1,271.00â–²(2.25% Upside)
Action:reiterated
Date:08/18/26

The overall score of 55 reflects a company with a strong, debt-free balance sheet that is offset by weak profitability and a high valuation. The company has returned to growth and positive cash flow, but low margins and historical volatility remain significant concerns. Neutral technicals and an expensive P/E ratio further limit the score.

Positive Factors
Debt-Free Balance SheetMinimal leverage reduces interest and refinancing risk while preserving financial flexibility. The substantial equity base can help C'BON withstand weaker operating periods and continue funding its directly managed cosmetics business.
Negative Factors
Thin Net ProfitabilityDespite high gross margins, only a small portion of sales reaches the bottom line, while returns on shareholder capital remain modest. This leaves limited protection against cost increases, weaker demand, or execution problems.

C'BON COSMETICS Co., Ltd. (4926) vs. iShares MSCI Japan ETF (EWJ)

-5%0%5%10%15%20%25%30%JP:4926+5.20%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 5.17B
Dividend Yield
1.61%
Average Volume (3M)
1,108
Price to Earnings (P/E)
20.9
Beta (1Y)
0.19
Revenue Growth
1.51%
EPS Growth
-18.54%
Country
Japan
Employees
717
Sector
Consumer Defensive
Sector Strength
62
Industry
Household & Personal Products

C'BON COSMETICS Co., Ltd. Business Overview & Revenue Model

Company Description

C'BON COSMETICS Co.,Ltd. is engaged in the development and distribution of a diverse range of beauty products, encompassing conventional cosmetics, quasi-pharmaceuticals, and aesthetic devices. Its comprehensive product line includes essentials such...

How the Company Makes Money

null

C'BON COSMETICS Co., Ltd. Financial Statement Overview

Summary

Financial performance is mixed. The debt-free balance sheet (Score 72) provides a strong foundation, but profitability is weak with low margins and a modest ROE. Cash flow improved significantly in the latest year but has a history of volatility. The overall trajectory is positive but carries risk.

Income Statement

55Neutral

Balance Sheet

72Positive

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.28B9.27B8.84B8.50B8.53B9.15B
Gross Profit7.10B7.03B6.74B6.40B6.34B7.10B
EBITDA465.25M454.62M292.59M168.63M-92.22M329.61M
Net Income249.48M213.61M136.27M-26.35M-421.77M44.87M
Balance Sheet
Total Assets8.43B8.60B8.60B8.81B8.84B9.56B
Cash, Cash Equivalents and Short-Term Investments2.69B3.02B2.65B3.63B3.98B2.80B
Total Debt0596.00K04.24M13.27M22.30M
Total Liabilities2.64B2.91B2.89B3.15B3.13B3.36B
Stockholders Equity5.79B5.69B5.70B5.66B5.71B6.20B
Cash Flow
Free Cash Flow0553.88M-926.52M-301.11M-693.60M330.15M
Operating Cash Flow0763.10M-43.16M278.19M-81.47M433.37M
Investing Cash Flow0-159.99M-849.16M-581.94M1.35B44.91M
Financing Cash Flow0-240.69M-90.22M-31.20M-91.29M-6.73M

C'BON COSMETICS Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price1243.00

Price Trends

50DMA1237.85Positive
100DMA1232.09Positive
200DMA1241.60Positive

Market Momentum

MACD1.12Positive
RSI55.30Neutral
STOCH66.67Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4926, the sentiment is Positive. The current price of 1243.00 is above the 20-day moving average (MA) of 1241.20, above the 50-day MA of 1237.85, and above the 200-day MA of 1241.60, indicating a bullish trend. The MACD of 1.12 indicates Positive momentum. The RSI at 55.30 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4926.

C'BON COSMETICS Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

JP:4926 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4925JP:492580OutperformJPY 6.30B9.22―2.40%-2.92%-25.96%
JP:4918JP:491874OutperformJPY 2.26B14.34―3.14%-5.54%-55.93%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
JP:4929JP:492956NeutralJPY 5.92B36.88―1.63%-1.71%314.83%
JP:4926JP:492655NeutralJPY 5.32B20.89―1.61%1.51%-18.54%
JP:4936JP:493651NeutralJPY 6.89B-13.82―3.56%-0.08%-246.12%
JP:4934JP:493450NeutralJPY 4.64B12.74――-14.09%-22.72%

* Consumer Defensive Sector Average

Performance Comparison

-20%0%20%40%JP:4926JP:4918JP:4925JP:4929JP:4934JP:4936Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4926 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4926C'BON COSMETICS Co., Ltd.1243.0061.405.20%
JP:4918Ivy Cosmetics Corporation478.00163.9852.22%
JP:4925HABA Laboratories, Inc.1660.0033.962.09%
JP:4929ADJUVANT HOLDINGS CO., LTD.735.00-9.91-1.33%
JP:4934Premier Anti-Aging Co., Ltd.532.00-166.00-23.78%
JP:4936AXXZIA, Inc.281.00-135.62-32.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 18, 2026